#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Castleman's disease Acquired C1 inhibitor deficiency Cutaneous T-cell lymphoma refractory Astrocytoma malignant Keratosis follicular Von Hippel-Lindau disease Nephropathy Neuropathic arthropathy Henoch-Schonlein purpura nephritis Malignant melanoma Turner's syndrome Colon cancer Squamous cell carcinoma of the hypopharynx Chronic granulomatous disease Pemphigoid More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Diagnostics Haemophilia A with anti factor VIII – Treatment Castleman’s disease – Diagnostics Congenital nephrogenic diabetes insipidus – Basic Information Richter’s syndrome – Trials in Disease Congenital generalised lipodystrophy Pemphigoid Medulloblastoma Lymphatic malformation Glomerulonephritis rapidly progressive – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Teprotumumab Axitinib Midostaurin Pf-06835375 Mercaptopurine Imifoplatin 13N-AMMONIA MORPHINE Jnj-81241459 SUMATRIPTAN Obinutuzumab Baloxavir Marboxil Etoposide Ng004 Lisinopril Rilpivirine Meldonium Prasugrel Hydrobromide Briquilimab Ecoo18A More therapies…

    Learn about Your Condition

    Pre-eclampsia Congenital pseudarthrosis Von Hippel-Lindau disease Basal cell carcinoma Metabolic surgery MELAS syndrome Mixed dementia Haematological malignancy Cold type haemolytic anaemia Anaemia of pregnancy Biliary cancer metastatic Iron deficiency anaemia Microscopic polyangiitis Progressive supranuclear palsy Breast cancer male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormonal diseases

  • Study on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia

    Not recruiting

    3 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Crinecerfont
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Noonan syndrome
    • Small for dates baby
    • Turner’s syndrome
    Investigated Drugs:
    • Somapacitan
    • Somatropin
    Austria Belgium Bulgaria Croatia Finland France +10

  • Study Comparing ARV-471 and Palbociclib with Letrozole and Palbociclib for Patients with Estrogen Receptor Positive, HER2-Negative Advanced Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Palbociclib
    • (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
    Hungary Italy Slovakia Spain

  • Study on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Siplizumab
    • Cetirizine Dihydrochloride
    • Paracetamol
    Belgium Italy Spain Sweden

  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Upacicalcet Sodium Hydrate
    Bulgaria Poland Portugal Spain

  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

    Not recruiting

    3 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Upacicalcet Sodium Hydrate
    Bulgaria Poland Portugal Spain
Previous Page
1 … 18 19 20 21 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!